Literature DB >> 11013181

Management of alkali burns : an 11-year retrospective review.

S C Brodovsky1, C A McCarty, G Snibson, M Loughnan, L Sullivan, M Daniell, H R Taylor.   

Abstract

OBJECTIVE: To review the spectrum of patients with alkali burns admitted over an 11-year period and to assess the clinical outcomes after the introduction of a standard alkali burn treatment protocol.
DESIGN: Retrospective nonrandomized comparative study. PATIENTS AND
INTERVENTIONS: A total of 121 patient records with alkali burns (n = 177 eyes) admitted to a tertiary hospital between 1987 and 1998 were reviewed. Eyes treated with a standard alkali burn treatment protocol, which included intensive topical steroids, ascorbate, citrate, and antibiotics, were compared with eyes treated by conservative management with antibiotics, and a short course of steroids. MAIN OUTCOME MEASURES: Time to corneal reepithelialization, final best-corrected visual acuity, and time to visual recovery, length of hospital stay, and complications were analyzed.
RESULTS: The standard protocol tended to delay corneal reepithelialization by one day (P: = not significant) in eyes with grade 1 burns (n = 76) and by 2 days (P: = 0.04) in grade 2 burns (n = 52), with no difference in final visual outcome. There were 37 eyes with grade 3 burns. Those treated with the standard protocol showed a trend toward more rapid corneal reepithelialization. Twenty-seven of 29 (93%) eyes with grade 3 injuries achieved a final best-corrected visual acuity of 20/40 or better compared with 3 of 6 (50%) eyes not treated according to the standard protocol (P: = 0.02). Eyes with grade 4 burns (n = 12), whether treated with the standard protocol or not, required 10 to 12 weeks for corneal reepithelialization. There was no statistically significant difference in final visual acuity.
CONCLUSIONS: On the basis of our findings, a number of recommendations can be made for the management of alkali injuries. Patients with a grade 1 or 2 injury do not require routine admission and do not benefit from the use of intensive treatment with ascorbate and citrate. A trend toward more rapid healing and a better final visual outcome were apparent in grade 3 burns, but our standard protocol made no difference in grade 4 burns.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11013181     DOI: 10.1016/s0161-6420(00)00289-x

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  46 in total

1.  A new classification of ocular surface burns.

Authors:  H S Dua; A J King; A Joseph
Journal:  Br J Ophthalmol       Date:  2001-11       Impact factor: 4.638

2.  The ocular surface toxicity of paraquat.

Authors:  D McKeag; R Maini; H R Taylor
Journal:  Br J Ophthalmol       Date:  2002-03       Impact factor: 4.638

3.  Modification of classification of ocular chemical injuries.

Authors:  S Harun; S Srinivasan; K Hollingworth; M Batterbury; S Kaye
Journal:  Br J Ophthalmol       Date:  2004-10       Impact factor: 4.638

4.  Proteomic analyses of corneal tissue subjected to alkali exposure.

Authors:  Toral Parikh; Natalie Eisner; Praseeda Venugopalan; Qin Yang; Byron L Lam; Sanjoy K Bhattacharya
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-01       Impact factor: 4.799

5.  In vivo confocal microscopy of early corneal epithelial recovery in patients with chemical injury.

Authors:  J Xiang; Q Le; Y Li; J Xu
Journal:  Eye (Lond)       Date:  2015-09-18       Impact factor: 3.775

6.  Loss of tumor necrosis factor alpha potentiates transforming growth factor beta-mediated pathogenic tissue response during wound healing.

Authors:  Shizuya Saika; Kazuo Ikeda; Osamu Yamanaka; Kathleen C Flanders; Yuka Okada; Takeshi Miyamoto; Ai Kitano; Akira Ooshima; Yuji Nakajima; Yoshitaka Ohnishi; Winston W-Y Kao
Journal:  Am J Pathol       Date:  2006-06       Impact factor: 4.307

7.  TRPA1 is required for TGF-β signaling and its loss blocks inflammatory fibrosis in mouse corneal stroma.

Authors:  Yuka Okada; Kumi Shirai; Peter S Reinach; Ai Kitano-Izutani; Masayasu Miyajima; Kathleen C Flanders; James V Jester; Makoto Tominaga; Shizuya Saika
Journal:  Lab Invest       Date:  2014-07-28       Impact factor: 5.662

8.  Mesenchymal stem cells improve healing of the cornea after alkali injury.

Authors:  Diamantis Almaliotis; Georgios Koliakos; Eleni Papakonstantinou; Anastasia Komnenou; Angelos Thomas; Spiros Petrakis; Ilias Nakos; Eleni Gounari; Vasileios Karampatakis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-05-23       Impact factor: 3.117

Review 9.  Is ophthalmology evidence based? A clinical audit of the emergency unit of a regional eye hospital.

Authors:  T Y Y Lai; V W Y Wong; G M Leung
Journal:  Br J Ophthalmol       Date:  2003-04       Impact factor: 4.638

10.  One-year follow-up of epithelial corneal cell sheet allografts mounted on platelet poor plasma in rabbits.

Authors:  Federico Luengo Gimeno; Victoria Lavigne; Silvia Gatto; J Oscar Croxatto; Laura Correa; Juan E Gallo
Journal:  Mol Vis       Date:  2009-12-15       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.